August 2022 A new Kunitz-type snake toxin family associated with an original mode of interaction with subgroup in the Kunitz family, close to the V2R non-active dendrotoxins and to two V2R-active cobra toxins

Industry News X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market Andrew

Andrew Hopkins, Exscientia's CEO, will speak at the University of Chicago's Distinguished Seminar Series

Andrew Tobin, Bryan Roth , Rosie Dawaliby , Steve Ferguson , Karen Gregory , Oliver Hartley , Juan Jose Humanized PTH1R Knockin Mice Effects of Small Molecule Ligands on ACKR3 Receptors A new Kunitz-type snake toxin

Our speakers include: Andrew Tobin , University of Glasgow Bryan Roth , University of North Carolina

Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic